- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT03966924
The PREFORM Study: Rotational Fractional Resection for Submental Contouring
April 20, 2021 updated by: Recros Medica, Inc.
The PREFORM Study: An Exploratory, Single-Center Study to Evaluate the Safety and Efficacy of Rotational Fractional Resection on Submental Contouring and Optimal Peri-Procedure Regimen for Accelerated Recovery
This study will evaluate the safety and efficacy of rotational fractional resection (RFR) to improve neck contouring.
Rotational fractional resection is used to remove loose skin and fat.
Study Overview
Status
Completed
Conditions
Intervention / Treatment
Detailed Description
This is a prospective, single-center, single-arm (non-randomized), interventional cohort, non-significant risk (NSR) study designed to investigate the efficacy and safety of Rotational Fractional Resection (skin resection and focal lipectomy) in patients with moderate to severe submental skin laxity.
The total duration of study participation for each subject is approximately up to 4 months for each subject from the screening visit to the exit visit.
The follow-up period will be approximately 3 months after the procedure.
Eligible subjects will complete a total of 11 study visits: screening, procedure, and follow-up visits at 1, 4, 7, 14, 21, 30, 45, 60, and 90 days post-procedure.
Study Type
Interventional
Enrollment (Actual)
2
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
California
-
Newport Beach, California, United States, 92663
- Steve Yoelin, MD Medical Associates, Inc.
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
30 years and older (Adult, Older Adult)
Accepts Healthy Volunteers
Yes
Genders Eligible for Study
All
Description
Inclusion Criteria:
- Healthy male or female
- At least 30 years old
- Moderate to severe submental laxity
- Up to moderate submental lipodystrophy
- Agree to maintain weight (±5%) for the duration of the study
Exclusion Criteria:
- Previous intervention to treat submental fat or skin laxity
- Use of aspirin, ibuprofen, naproxen, or Vitamin E within 14 days of the procedure
- Severe acne, cystic acne or acne scars on neck
- Trauma of chin or neck area
- Skin infection or rash on neck
- Psoriasis, hyperpigmentation, eczema, rosacea or vitiligo
- History of scarring
- Body mass index (BMI) >30
- Clinically significant bleeding disorder
- Anemia, kidney disease, or liver disease
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: N/A
- Interventional Model: Single Group Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Experimental: Rotational fractional resection (1.5mm Diameter Device)
Single treatment of skin resection and with and without focal lipectomy (removal of loose skin and fat)
|
Single treatment of skin resection and with and without focal lipectomy (removal of loose skin and fat)
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Number of Participants Who Had at Least One Grade Improvement on the Submental Skin Laxity Scale
Time Frame: 90 days post treatment
|
Physician investigator rated the submental laxity using the Submental Skin Laxity scale (0 = none, 1 = mild, 2 = moderate, 3 = severe, 4 = very severe)
|
90 days post treatment
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Number of Participants Who Were Satisfied With the Appearance of Their Neck and Jawline
Time Frame: 90 days post treatment
|
Subjects rated their satisfaction of the appearance of their neck and jawline on a Subject Satisfaction Questionnaire.
Results reflect subjects who were satisfied ("somewhat satisfied," "satisfied," or "very satisfied").
|
90 days post treatment
|
Number of Participants With a One Grade Improvement on the Submental Lipodystrophy Scale
Time Frame: 90 days post treatment
|
Comparison of the submental fat before and after procedure using the Submental Skin Lipodystrophy scale (0 = none, 1 = mild, 2 = moderate, 3 = severe, 4 = very severe)
|
90 days post treatment
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
March 20, 2019
Primary Completion (Actual)
October 16, 2019
Study Completion (Actual)
October 16, 2019
Study Registration Dates
First Submitted
March 19, 2019
First Submitted That Met QC Criteria
May 28, 2019
First Posted (Actual)
May 29, 2019
Study Record Updates
Last Update Posted (Actual)
May 11, 2021
Last Update Submitted That Met QC Criteria
April 20, 2021
Last Verified
January 1, 2020
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- CLP-0007
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
NO
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
Yes
product manufactured in and exported from the U.S.
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Lipodystrophy
-
Aegerion Pharmaceuticals, Inc.RecruitingPartial Lipodystrophy | Generalised LipodystrophyUnited States, Germany, Italy
-
University Hospital, LilleRecruitingFamilial Partial Lipodystrophy Type 2France
-
Amryt PharmaRecruitingPartial LipodystrophyUnited States, Canada
-
University of UlmUniversity of Pisa; IRCCS Azienda Ospedaliero-Universitaria di Bologna; Medical... and other collaboratorsRecruitingLipodystrophy Acquired | Lipodystrophy CongenitalAustria, France, Germany, Hungary, Italy, Portugal, Spain, Netherlands, Russian Federation, Slovenia, Switzerland, Turkey, United Kingdom
-
Regeneron PharmaceuticalsAvailablePartial Lipodystrophy | Generalized Lipodystrophy | Monogenic Obesity Due to LEP or LEPR Loss of Function
-
University of Texas Southwestern Medical CenterCompletedInsulin Resistance | Partial Lipodystrophy | Generalized Lipodystrophy | HypoleptinemiaUnited States
-
Regeneron PharmaceuticalsActive, not recruitingGeneralized LipodystrophyUnited States, Peru, Russian Federation, Turkey
-
Mayo ClinicCompleted
-
Escola Superior de Tecnologia da Saúde do PortoCompleted
-
University of Texas Southwestern Medical CenterTerminated
Clinical Trials on Rotational fractional resection (1.5mm Diameter Device)
-
Recros Medica, Inc.CompletedLipodystrophy | Skin LaxityUnited States